Latest Content

Reflecting on Holocaust Remembrance Day, H. Steven Moffic, MD, connects past traumas to present challenges, emphasizing the importance of memory and healing.

The FDA has accepted for priority review an NDA for Otsuka's centanafadine, a novel ADHD treatment.

Explore the evolution of social psychiatry, highlighting key achievements and future directions from the World Association of Social Psychiatry's 60th anniversary.

Neurocrine Biosciences launches a phase 2 trial for NBI-1065890.

Sleep is vital for athlete patients, enhancing performance, mental health, and recovery. Discover effective strategies to optimize sleep for peak athletic success.

Explore the complexities of aging, mental health challenges, and the unique opportunities that come with turning 80 in today's society.

LB Pharmaceuticals initiates a phase 2 trial for LB-102, a promising treatment for bipolar depression, aiming to address unmet needs in mood disorders.

What is new in research on major depressive disorder?

Explore the gradual dangers of societal issues like climate change and mental health, and learn how early intervention can make a difference.

Therapeutic drug monitoring revolutionizes psychiatric care, enhancing treatment precision and patient outcomes through real-time data and personalized medicine strategies.

Explore the concept of interdependence in politics and psychiatry, emphasizing connection and cooperation to enhance mental health and societal well-being.